Literature DB >> 23723606

Extensive Invasive Extramammary Paget's Disease: Surgical Treatment.

Uwe Wollina1.   

Abstract

Extramammary Paget's disease is uncommon. Diagnosis has to be confirmed by histopathology. Treatment is a challenge in cases with extended tumors. We present a 70-year-old male patient with extensive genitoanal Paget's disease. Mohs surgery is the gold standard in such cases. Details of the surgical planning are discussed including wound bed preparation. Radiotherapy may be an alternative.

Entities:  

Keywords:  Apocrine malignancy; Extramammary Paget's disease; Mohs surgery; transplantation

Year:  2013        PMID: 23723606      PMCID: PMC3663178          DOI: 10.4103/0974-2077.110098

Source DB:  PubMed          Journal:  J Cutan Aesthet Surg        ISSN: 0974-2077


INTRODUCTION

Invasive extramammary Paget's disease (IEMPD) is uncommon. The predominant area of development is the anogenital region followed by the axillary skin. It affects mainly elderly people.[1] Basically, this tumor is an adenocarcinoma of apocrine gland origin. Histopathology demonstrates large single cells or cell nests throughout the epidermis in Paget's disease. Tumor cells are positive for periodic-acid-Schiff stain (PAS), cytokeratin 7 (CK7), and carcino-embryonal antigen (CEA) but remain negative for S100 or HMB-45. Immunohistology helps to distinguish IEMPD for pagetoid melanoma (S100 and HMB-45 positive, but CK7, CEA, and PAS negative).[2] Six different patterns of Paget cell proliferation have been described. Upper nests or a mixture of at least three patterns has been considered as suggestive for IEMPD.[3] IEMPD shows a complete loss of Wnt (wingless-type MMTV integration site)-5α.[4] In addition, several protein kinases involved in the c-Jun amino-terminal kinase pathway are overexpressed in IEMPD: Hematopoietic progenitor kinase-1, mitogen-activated protein/extracellular signal-related protein kinase kinase kinase-1, and phosphomitogen-activated protein kinase kinase-4.[5] The over expression of HER-2/neu (c-erbB-2) is correlated to invasiveness of lymph node metastasis.[6] European age standardized incidence of EMPD is 0.6 per 1000,000 person years. Five-year relative survival for invasive EMPD is 91.2%. Among European patients 8.6% developed other malignancies.[7] The percentage of secondary tumours is 14.4% in South Korea.[8] The highest increased risk of developing a second primary tumour was found in the first year of follow-up or being female. These findings argue for thorough search for other tumours during follow-up.[78]

CASE REPORT

A 70-year-old Causasian male patient of good general health presented with a persistent scaling erythematous lesion on his groins with ill-defined margins. He reported no itching or other subjective symptoms. The lesions were slow growing for more than 5 years. Topical treatment with corticosteroids or anti-mycotics had not improved the cutaneous appearance. His personal and family medical history was unremarkable. On examination we observed an extensive erythematous lesion of groins, perineum and proximal parts of scrotal skin with peripheral scaling and central oozing [Figure 1]. Inguinal lymph nodes were not palpable.
Figure 1

Clinical aspect of extensive extramammary invasive Pagetæs disease with involvement of groins scrotum and perineum

Clinical aspect of extensive extramammary invasive Pagetæs disease with involvement of groins scrotum and perineum Laboratory investigations were unremarkable except a slightly increase level of carcinoembryonal antigen (CEA) of 2.2 μg/L. Microbial swabs were taken for bacterial cultures but remained sterile. We took a diagnostic biopsy from the left groin in the centre of the lesions. It was suggesting Paget's disease. Diagnostic ultrasound for lymph nodes demonstrated some enlarged nodes. A control was suggested. The ultrasound control 6 weeks later was normal. Screening for second tumour including skin (total body investigation including dermoscopy), lung (computerized tomography), prostate (digital examination, ultrasound and prostate-specific antigen), and GIT (coloscopy) remained negative. Treatment and course: We performed complete surgical excision with delayed Mohs techniques [Figure 2]. The histopathological work-up revealed a Paget carcinoma (apocrine adenocarcinoma) surrounded by intraepidermal Paget's disease [Figure 3]. The invasive part was completely excised with the 1st surgery. Paget's disease was noticed in minor parts of the surgical margins. Therefore, re-excision of the margins was done twice with delayed Mohs technique, i.e., complete examination of all margins. Controls demonstrated no Paget's residues. The distance between surgical border and anal verge was 2 cm. Wound bed was prepared by repeated topical CO2 application under plastic foil for 20 min. Hereby granulation was improved. The resulting defect was closed by split-skin mesh-graft and the scrotum was partially reconstructed by extension of scrotal skin [Figure 4]. The healing was uneventful and the outcome was functionally and esthetical very good [Figure 5].
Figure 2a

Surgical situs after Mohs surgery

Figure 3

Histopathology of the tumor with pagetoid cell proliferations and invasive growth (H and E, ×4)

Figure 4

Mesh-graft split skin transplantation after induction of granulation by topical CO2

Figure 5

Good functional and esthetic outcome

Surgical situs after Mohs surgery The excised tumor Histopathology of the tumor with pagetoid cell proliferations and invasive growth (H and E, ×4) Mesh-graft split skin transplantation after induction of granulation by topical CO2 Good functional and esthetic outcome During follow-up of three months the patient was relapse-free. A regular follow-up every 3 months during the first year and twice a year for a total of five years is planned.

DISCUSSION

Extramammary Paget's disease is uncommon. The differential diagnosis includes inverse psoriasis, eczema, intertrigio, tinea and mycosis fungoides. The anogenital region is the most common involved area, but scrotal disease is less common.[19] Standard therapy is complete surgical excision with 2 cm to 5 cm safety margin or Mohs surgery.[10-13] Mohs surgery may be supported by immunostaining for cytokeratin 17 expressed by EMPD.[14] Recurrence rates after standard surgical excision range from 33% to 62.5% versus 16% to 28% after Mohs surgery.[11-13] Non-surgical treatments have been used either in non-invasive EMPD or recurrent EMPD. Topical imiquimod may produce long-term remissions in smaller tumors but not in all.[14-17] Photodynamic therapy fails to achieve complete remissions especially in larger tumours.[1819] Other options include topical 5-fluorouracil, topical bleomycin, CO2-laser, docetaxel, and radiotherapy.[120] Whereas surgery remains the golden standard, in extensive disease defect closure may become difficult. Various techniques have been used including split skin mesh graft transplants with or without vacuum-assisted closure, and a number of flaps, especially when deep arteries are exposed.[1102122] Although flaps allow a rapid closure of defects, the long term outcome of pendiculated flaps often bears the risk of local lymphedema. This can be circumvented by preparation of wound ground and delayed split skin grafting as in our case. We use repeated topical CO2 application to improve granulation of wound bed tissue.[23]
  23 in total

1.  Complete remission of advanced extramammary Paget's disease treated with docetaxel: a case report.

Authors:  R Nakamori; Y Omoto; K Yamanaka; K Habe; I Kurokawa; H Mizutani
Journal:  Clin Exp Dermatol       Date:  2011-10-18       Impact factor: 3.470

Review 2.  Extra-mammary Paget's disease of the perianal region: a review of the literature emphasizing the operative management technique.

Authors:  Ioannis D Kyriazanos; Nikolaos P Stamos; Lazaros Miliadis; Grigorios Noussis; Christos N Stoidis
Journal:  Surg Oncol       Date:  2011-06       Impact factor: 3.279

3.  Transdermal CO2 application in chronic wounds.

Authors:  U Wollina; Birgit Heinig; Christine Uhlemann
Journal:  Int J Low Extrem Wounds       Date:  2004-06       Impact factor: 2.057

4.  Loss of Wnt-5α is associated with an invasive phenotype of extramammary Paget's disease.

Authors:  Lining Xie; Sayaka Hayashida; Masutaka Furue
Journal:  J Cutan Pathol       Date:  2011-02-24       Impact factor: 1.587

5.  Extramammary Paget's disease: extended subclinical growth detected using three-dimensional histology in routine paraffin procedure and course of the disease.

Authors:  Alexandra Boehringer; Ulrike Leiter; Gisela Metzler; Matthias Moehrle; Claus Garbe; Helmut Breuninger
Journal:  Dermatol Surg       Date:  2011-07-18       Impact factor: 3.398

6.  Hematopoietic progenitor kinase 1, mitogen-activated protein/extracellular signal-related protein kinase kinase kinase 1, and phosphomitogen-activated protein kinase kinase 4 are overexpressed in extramammary Paget disease.

Authors:  Yue Qian; Satoshi Takeuchi; Long Dugu; Gaku Tsuji; Lining Xie; Takeshi Nakahara; Masakazu Takahara; Yoichi Moroi; Ya-Ting Tu; Masutaka Furue
Journal:  Am J Dermatopathol       Date:  2011-10       Impact factor: 1.533

Review 7.  Extramammary Paget's disease: Summary of current knowledge.

Authors:  Christina Lam; Deana Funaro
Journal:  Dermatol Clin       Date:  2010-10       Impact factor: 3.478

8.  Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery.

Authors:  Ali Hendi; David G Brodland; John A Zitelli
Journal:  J Am Acad Dermatol       Date:  2004-11       Impact factor: 11.527

9.  Extramammary Paget Disease of the Axilla Associated With Comedo-like Apocrine Carcinoma In Situ.

Authors:  Elena Castelli; Uwe Wollina; Antonino Anzarone; Vincenza Morello; Rosa Maria Tomasino
Journal:  Am J Dermatopathol       Date:  2002-08       Impact factor: 1.533

10.  Extramammary Paget's disease: evaluation of the histopathological patterns of Paget cell proliferation in the epidermis.

Authors:  Tatsushi Shiomi; Yuichi Yoshida; Kohei Shomori; Osamu Yamamoto; Hisao Ito
Journal:  J Dermatol       Date:  2011-09-23       Impact factor: 3.468

View more
  3 in total

Review 1.  Surgical Treatment for Extramammary Paget's Disease.

Authors:  Uwe Wollina; Alberto Goldman; Andrzej Bieneck; Mohamed Badawy Abdel-Naser; Sven Petersen
Journal:  Curr Treat Options Oncol       Date:  2018-05-03

2.  Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget's Disease of the Vulva.

Authors:  Marina Stasenko; Gowtham Jayakumaran; Renee Cowan; Vance Broach; Dennis S Chi; Anthony Rossi; Travis J Hollman; Ahmet Zehir; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  JCO Precis Oncol       Date:  2020-09-15

3.  Two cases of Paget's disease of scrotum in biological brothers.

Authors:  Dapang Rao; Haibo Zhu; Kaiyuan Yu; Haifeng Yu; Liping Xie
Journal:  Ther Clin Risk Manag       Date:  2015-05-27       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.